Form 8-K - Current report:
SEC Accession No. 0001104659-22-023794
Filing Date
2022-02-15
Accepted
2022-02-15 16:10:38
Documents
12
Period of Report
2022-02-15
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm226789d1_8k.htm   iXBRL 8-K 26705
  Complete submission text file 0001104659-22-023794.txt   198521

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA anip-20220215.xsd EX-101.SCH 3063
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20220215_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20220215_pre.xml EX-101.PRE 22615
6 EXTRACTED XBRL INSTANCE DOCUMENT tm226789d1_8k_htm.xml XML 3464
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

EIN.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 22639263
SIC: 2834 Pharmaceutical Preparations